Jochen Lorch
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer (NCT06959641) | Jochen Lorch | 2025-06-06 |
Track Jochen Lorch automatically
Every clearance here is in the API, with alerts when new ones post.